List of Tables
Table 1. Global Human Vaccines Administered Orally Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Vaccines Administered Orally Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Vaccines Administered Orally Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Vaccines Administered Orally Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Vaccines Administered Orally Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Vaccines Administered Orally Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Vaccines Administered Orally Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Vaccines Administered Orally Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Vaccines Administered Orally, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Vaccines Administered Orally, Product Type & Application
Table 12. Global Key Manufacturers of Human Vaccines Administered Orally, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Vaccines Administered Orally by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccines Administered Orally as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Vaccines Administered Orally Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Vaccines Administered Orally Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Vaccines Administered Orally Sales Market Share by Region (2020-2025)
Table 19. Global Human Vaccines Administered Orally Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Vaccines Administered Orally Sales Market Share by Region (2026-2031)
Table 21. Global Human Vaccines Administered Orally Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Vaccines Administered Orally Revenue Market Share by Region (2020-2025)
Table 23. Global Human Vaccines Administered Orally Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Vaccines Administered Orally Revenue Market Share by Region (2026-2031)
Table 25. North America Human Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Vaccines Administered Orally Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Vaccines Administered Orally Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Vaccines Administered Orally Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Vaccines Administered Orally Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Vaccines Administered Orally Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Vaccines Administered Orally Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Vaccines Administered Orally Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Vaccines Administered Orally Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Vaccines Administered Orally Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Vaccines Administered Orally Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Vaccines Administered Orally Sales (K Units) by Type (2020-2025)
Table 51. Global Human Vaccines Administered Orally Sales (K Units) by Type (2026-2031)
Table 52. Global Human Vaccines Administered Orally Sales Market Share by Type (2020-2025)
Table 53. Global Human Vaccines Administered Orally Sales Market Share by Type (2026-2031)
Table 54. Global Human Vaccines Administered Orally Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Vaccines Administered Orally Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Vaccines Administered Orally Revenue Market Share by Type (2020-2025)
Table 57. Global Human Vaccines Administered Orally Revenue Market Share by Type (2026-2031)
Table 58. Global Human Vaccines Administered Orally Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Vaccines Administered Orally Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Vaccines Administered Orally Sales (K Units) by Application (2020-2025)
Table 61. Global Human Vaccines Administered Orally Sales (K Units) by Application (2026-2031)
Table 62. Global Human Vaccines Administered Orally Sales Market Share by Application (2020-2025)
Table 63. Global Human Vaccines Administered Orally Sales Market Share by Application (2026-2031)
Table 64. Global Human Vaccines Administered Orally Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Vaccines Administered Orally Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Vaccines Administered Orally Revenue Market Share by Application (2020-2025)
Table 67. Global Human Vaccines Administered Orally Revenue Market Share by Application (2026-2031)
Table 68. Global Human Vaccines Administered Orally Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Vaccines Administered Orally Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Human Vaccines Administered Orally Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Human Vaccines Administered Orally Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Human Vaccines Administered Orally Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Company Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lanzhou Institute Human Vaccines Administered Orally Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Company Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Serum Institute Human Vaccines Administered Orally Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Company Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Human Vaccines Administered Orally Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Company Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Human Vaccines Administered Orally Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Company Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bibcol Human Vaccines Administered Orally Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Company Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. PaxVax Human Vaccines Administered Orally Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Company Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Vabiotech Human Vaccines Administered Orally Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Company Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tiantan Biological Human Vaccines Administered Orally Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Company Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. EuBiologics Human Vaccines Administered Orally Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Company Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Panacea Biotec Ltd Human Vaccines Administered Orally Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Company Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bio-Med Human Vaccines Administered Orally Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Company Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Human Vaccines Administered Orally Distributors List
Table 148. Human Vaccines Administered Orally Customers List
Table 149. Human Vaccines Administered Orally Market Trends
Table 150. Human Vaccines Administered Orally Market Drivers
Table 151. Human Vaccines Administered Orally Market Challenges
Table 152. Human Vaccines Administered Orally Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Vaccines Administered Orally
Figure 2. Global Human Vaccines Administered Orally Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Vaccines Administered Orally Market Share by Type: 2024 & 2031
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Global Human Vaccines Administered Orally Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Human Vaccines Administered Orally Market Share by Application: 2024 & 2031
Figure 9. Public
Figure 10. Private
Figure 11. Global Human Vaccines Administered Orally Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Vaccines Administered Orally Market Size (2020-2031) & (US$ Million)
Figure 13. Global Human Vaccines Administered Orally Sales (2020-2031) & (K Units)
Figure 14. Global Human Vaccines Administered Orally Average Price (US$/Unit) & (2020-2031)
Figure 15. Human Vaccines Administered Orally Report Years Considered
Figure 16. Human Vaccines Administered Orally Sales Share by Manufacturers in 2024
Figure 17. Global Human Vaccines Administered Orally Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Human Vaccines Administered Orally Players: Market Share by Revenue in Human Vaccines Administered Orally in 2024
Figure 19. Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Human Vaccines Administered Orally Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Human Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 22. North America Human Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 23. United States Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Human Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 26. Europe Human Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 27. Germany Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Human Vaccines Administered Orally Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Human Vaccines Administered Orally Revenue Market Share by Region (2020-2031)
Figure 34. China Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Human Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 44. Latin America Human Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Human Vaccines Administered Orally Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Vaccines Administered Orally Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Human Vaccines Administered Orally Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Human Vaccines Administered Orally by Type (2020-2031)
Figure 54. Global Revenue Market Share of Human Vaccines Administered Orally by Type (2020-2031)
Figure 55. Global Human Vaccines Administered Orally Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Human Vaccines Administered Orally by Application (2020-2031)
Figure 57. Global Revenue Market Share of Human Vaccines Administered Orally by Application (2020-2031)
Figure 58. Global Human Vaccines Administered Orally Price (US$/Unit) by Application (2020-2031)
Figure 59. Human Vaccines Administered Orally Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
